grant opportunities
Apply for the Biopsy Catchment Biobank Investigators Award
Applicants must propose original research that contributes to the understanding of the clinical and/or health economic benefits for biobanks of utilizing dislodged tumor cells following core needle biopsies recovered via the Crow’s Nest™ Biopsy Catchment System.
The Crow’s Nest™ Biospy Catchment System is used at the point-of-procedure site for core needle biopsies. This portable, disposable tool is capable of creating two specimens from the original singular tissue specimen. This second specimen created contains viable cells, free from exposure to formalin and with minimal pre-analytic variables – by utilizing only the dislodged cells on the needle that would have otherwise been discarded as medical waste. This material represents a valuable, untapped resource for biobanks that is fully representative of the parent tissue core yet is currently discarded with the needle.
Grant Eligibility and Purpose
Corramedical is seeking to solicit the expertise in the biobanking community and develop evidence for the utility of these recovered cells or analytes inherent to them for downstream research needs. Emerging technologies in multiple ‘omic fields have the potential to benefit from this clinical material and drive their adoption into clinical practice.
The winning proposal will contain froward-thinking integrated biobanking workflows that will bring value to (a) the biobanking community, and to (b) downstream users in the biomarker diagnostic ecosphere in academia and pharma.
Goal
- Proposals capable of demonstrating specific or multiomic-centric biobanking approaches with plans on how to test and confirm yields of the informative analytes from the material recovered by using the Crow’s Nest device will be prioritized. Researchers should be willing to engage with the oncology, pathology, and/or interventional radiology communities, sharing insights and findings from their work.
- This 2025 grant cycle is open to U.S. -based applicants. Eligibility is maintained for applicants who may also be recipients of funding from external sources.
- Recipients are expected to acknowledge the Crow’s Nest™ Biopsy Catchment System in the methods section of their manuscripts.
- Applicants and grant recipients may speak with a Corramedical-affiliated pathologist for a free consultation on your project.
Selection
Award
How to Apply
Submit
500-word maximum proposal detailing the role of the cell(s) or analyte(s) to be recovered by using the Crow’s Nest, their potential role as a biomarker or use in clinical investigative purposes, and how they will tested
Name
Institution
Is routine molecular testing (e.g. NGS) of core needle biopsy specimens performed in-house at your institution, or sent out to a 3rd party lab? If sent out, which lab is most often used?
Proposed Budget (please be as detailed as possible)
Hypothesis to be investigated
Link to LinkedIn profile
Your institution’s approximate rate of “Quantity No Sufficient” (“QNS”) from your biopsy testing results
Approximately how many core needle biopsy procedures per week are performed at your institution
Anticipated measurable outcomes
Stats of your biobank (size, volume of specimens added per year)
Previous relevant publications that you have been involved with
- Applications will be judged on a rolling basis.
- Judging of applications may begin as soon as July 1, 2025, and will continue throughout 2025.
- Three (3) awards of $5,000 each are expected to be awarded in 2025.
Logistical Details
